Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiyi Baitouweng Decoction is a traditional Chinese medicine (TCM) herbal formula used primarily for the treatment of intestinal-related diseases, especially ulcerative colitis (UC). The prescription typically includes Baitouweng (Pulsatilla chinensis), Huangbai (Phellodendron chinense), Huanglian (Coptis chinensis), Qinpi (Fraxinus chinensis), Yiyiren (Coicis Semen/Job’s tears seed), Diyu, Wubeizi, Baijiangcao, and Cheqianzi. The formula is believed to work by invigorating the spleen to eliminate dampness, clearing heat and toxins, promoting discharge of pus, and repairing the intestinal mucosal barrier. Mechanistically, it has been shown in preclinical studies to reduce proinflammatory cytokines such as IL-6, IL-1β and TNF-α; promote repair of the intestinal epithelial barrier by enhancing tight junction proteins; regulate tryptophan metabolism away from kynurenine towards indole metabolites; and activate aryl hydrocarbon receptor signaling pathways that restore gut barrier function[1][3][5]. Clinical studies suggest efficacy in improving symptoms of UC with a favorable safety profile[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yiyi baitouweng decoction.